One year ago today, President Obama signed the Patient Protection and Affordable Care Act into law. The legislative process that led to the bill's enactment proved to be a boon to lobbyists, including former aides to key members. Industry exerted influence on the administration and members of Congress from early on in the process, and continued lobbying after the bill was passed.
In 2009 and 2010, lobbyists for some 1,251 organizations disclosed lobbying on the bill, according to the Center for Responsive Politics. Those interests included pharmaceutical firms and their trade group, the Pharmaceutical Research and Manufacturers of America, insurers like Blue Cross/Blue Shield, the American Hospital Association, the American Medical Association, universities, retailers, restaurant chains, manufacturers, telecommunications firms and labor unions.
หนึ่งปีหลังจากผ่านการปฏิรูปการดูแลสุขภาพอย่างต่อเนื่องเพื่อสร้างค่าการล็อบบี้และทางกฎหมาย
หนึ่งปีที่ผ่านมาในวันนี้ประธานาธิบดีโอบามาลงนามในผู้ป่วยการดูแลป้องกันและราคาไม่แพงพระราชบัญญัติเป็นกฎหมาย กระบวนการนิติบัญญัติที่นำไปสู่การตรากฎหมายเรียกเก็บเงินของการพิสูจน์ให้เป็นประโยชน์เพื่อ lobbyists รวมทั้ง aides อดีตไปยังสมาชิกหลัก อุตสาหกรรมการกระทำมีอิทธิพลต่อการบริหารและสมาชิกสภาคองเกรสจากในช่วงต้นของกระบวนการและการล็อบบี้อย่างต่อเนื่องหลังจากที่เรียกเก็บเงินก็ผ่านไปได้
ในปี 2009 และ 2010, lobbyists สำหรับบาง 1,251 องค์กรเปิดเผยการล็อบบี้ในบิล, ตามศูนย์ตอบสนองการเมือง ผลประโยชน์ที่รวม บริษัท ยาและกลุ่มการค้า, การวิจัยและการผลิตยาของอเมริกาของพวกเขา บริษัท ผู้รับประกันภัยชอบ Blue Cross / Blue Shield, สมาคมโรงพยาบาลอเมริกัน, American Medical Association, มหาวิทยาลัย, ค้าปลีก, กลุ่มร้านอาหาร, ผู้ผลิต, บริษัท โทรคมนาคมและสหภาพแรงงาน .
หนึ่งปีที่ผ่านมาในวันนี้ประธานาธิบดีโอบามาลงนามในผู้ป่วยการดูแลป้องกันและราคาไม่แพงพระราชบัญญัติเป็นกฎหมาย กระบวนการนิติบัญญัติที่นำไปสู่การตรากฎหมายเรียกเก็บเงินของการพิสูจน์ให้เป็นประโยชน์เพื่อ lobbyists รวมทั้ง aides อดีตไปยังสมาชิกหลัก อุตสาหกรรมการกระทำมีอิทธิพลต่อการบริหารและสมาชิกสภาคองเกรสจากในช่วงต้นของกระบวนการและการล็อบบี้อย่างต่อเนื่องหลังจากที่เรียกเก็บเงินก็ผ่านไปได้
ในปี 2009 และ 2010, lobbyists สำหรับบาง 1,251 องค์กรเปิดเผยการล็อบบี้ในบิล, ตามศูนย์ตอบสนองการเมือง ผลประโยชน์ที่รวม บริษัท ยาและกลุ่มการค้า, การวิจัยและการผลิตยาของอเมริกาของพวกเขา บริษัท ผู้รับประกันภัยชอบ Blue Cross / Blue Shield, สมาคมโรงพยาบาลอเมริกัน, American Medical Association, มหาวิทยาลัย, ค้าปลีก, กลุ่มร้านอาหาร, ผู้ผลิต, บริษัท โทรคมนาคมและสหภาพแรงงาน .
Un anno dopo il passaggio, la riforma sanitaria continua agenerare spese di lobbying e di diritto
Un anno fa oggi, il presidente Obama ha firmato la protezione del paziente e non costose legge in legge. Il processo legislativo che ha portato alla promulgazione del disegno di legge si è rivelata un vantaggio per i lobbisti, tra cui ex collaboratori di membri chiave.Industria esercitato un'influenza sulla gestione e membri delCongresso fin dalle prime fasi del processo, e ha continuatolobbying dopo il disegno di legge è stata approvata.
Nel 2009 e nel 2010, 1.251 lobbisti per alcune organizzazionicomunicati lobbying sul disegno di legge, secondo il Center for Responsive Politics. Tali interessi incluso le impresefarmaceutiche e del loro gruppo commerciale, la ricerca farmaceutica e Produttori di America, gli assicuratori, come Blue Cross / Blue Shield, l'American Hospital Association, l'American Medical Association, università, commercianti, catene di ristoranti, produttori, società di telecomunicazioni e sindacati .
Un anno fa oggi, il presidente Obama ha firmato la protezione del paziente e non costose legge in legge. Il processo legislativo che ha portato alla promulgazione del disegno di legge si è rivelata un vantaggio per i lobbisti, tra cui ex collaboratori di membri chiave.Industria esercitato un'influenza sulla gestione e membri delCongresso fin dalle prime fasi del processo, e ha continuatolobbying dopo il disegno di legge è stata approvata.
Nel 2009 e nel 2010, 1.251 lobbisti per alcune organizzazionicomunicati lobbying sul disegno di legge, secondo il Center for Responsive Politics. Tali interessi incluso le impresefarmaceutiche e del loro gruppo commerciale, la ricerca farmaceutica e Produttori di America, gli assicuratori, come Blue Cross / Blue Shield, l'American Hospital Association, l'American Medical Association, università, commercianti, catene di ristoranti, produttori, società di telecomunicazioni e sindacati .
Un anno dopo il passaggio, la riforma sanitaria continua a generare spese di lobbying e di diritto
Un anno fa oggi, il presidente Obama ha firmato la protezione del paziente e non costose legge in legge. Il processo legislativo che ha portato alla promulgazione del disegno di legge si è rivelata un vantaggio per i lobbisti, tra cui ex collaboratori di membri chiave. Industria esercitato un'influenza sulla gestione e membri del Congresso fin dalle prime fasi del processo, e ha continuato lobbying dopo il disegno di legge è stata approvata.
Nel 2009 e nel 2010, 1.251 lobbisti per alcune organizzazioni comunicati lobbying sul disegno di legge, secondo il Center for Responsive Politics. Tali interessi incluso le imprese farmaceutiche e del loro gruppo commerciale, la ricerca farmaceutica e Produttori di America, gli assicuratori, come Blue Cross / Blue Shield, l'American Hospital Association, l'American Medical Association, università, commercianti, catene di ristoranti, produttori, società di telecomunicazioni e sindacati .
Un anno fa oggi, il presidente Obama ha firmato la protezione del paziente e non costose legge in legge. Il processo legislativo che ha portato alla promulgazione del disegno di legge si è rivelata un vantaggio per i lobbisti, tra cui ex collaboratori di membri chiave. Industria esercitato un'influenza sulla gestione e membri del Congresso fin dalle prime fasi del processo, e ha continuato lobbying dopo il disegno di legge è stata approvata.
Nel 2009 e nel 2010, 1.251 lobbisti per alcune organizzazioni comunicati lobbying sul disegno di legge, secondo il Center for Responsive Politics. Tali interessi incluso le imprese farmaceutiche e del loro gruppo commerciale, la ricerca farmaceutica e Produttori di America, gli assicuratori, come Blue Cross / Blue Shield, l'American Hospital Association, l'American Medical Association, università, commercianti, catene di ristoranti, produttori, società di telecomunicazioni e sindacati .
Post annum loco manet reformare valetudinis generare feodis et actiones lobbying
Unus annus abhinc hodie President Obama signed Praesidium et patiens Care Act Maecenas tristique in lege. Processus legislativa duxit rogationem lata's probavit lobbyists beneficium, etiam ut illa Tite key members. Industry invita pertingit ad administrationem a sodales Congress mane in processu, pergit billa lobbying lata.
In et MMIX MMX, aliquod lobbyists aperit 1.251 Institutionum liber in lobbying secundum Center for Politics responsive. Pharmaceutical studia inclusa et negotia nem coetus in Pharmaceutical Manufacturers lucubrationes Americae Blue Cross ut insurers / Blue Shield, Hospital Association American, American Association Medical, academias, Retailers Restaurant vinculis manufacturers, nem et labore Telecommunications uniones .
Unus annus abhinc hodie President Obama signed Praesidium et patiens Care Act Maecenas tristique in lege. Processus legislativa duxit rogationem lata's probavit lobbyists beneficium, etiam ut illa Tite key members. Industry invita pertingit ad administrationem a sodales Congress mane in processu, pergit billa lobbying lata.
In et MMIX MMX, aliquod lobbyists aperit 1.251 Institutionum liber in lobbying secundum Center for Politics responsive. Pharmaceutical studia inclusa et negotia nem coetus in Pharmaceutical Manufacturers lucubrationes Americae Blue Cross ut insurers / Blue Shield, Hospital Association American, American Association Medical, academias, Retailers Restaurant vinculis manufacturers, nem et labore Telecommunications uniones .
No comments:
Post a Comment